Vericel Corp (VCEL)
47.83
-0.05
(-0.10%)
USD |
NASDAQ |
May 03, 16:00
47.81
-0.02
(-0.04%)
After-Hours: 20:00
Vericel Market Cap: 2.310B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.310B |
| May 02, 2024 | 2.312B |
| May 01, 2024 | 2.274B |
| April 30, 2024 | 2.215B |
| April 29, 2024 | 2.254B |
| April 26, 2024 | 2.224B |
| April 25, 2024 | 2.195B |
| April 24, 2024 | 2.227B |
| April 23, 2024 | 2.242B |
| April 22, 2024 | 2.191B |
| April 19, 2024 | 2.112B |
| April 18, 2024 | 2.118B |
| April 17, 2024 | 2.234B |
| April 16, 2024 | 2.295B |
| April 15, 2024 | 2.352B |
| April 12, 2024 | 2.313B |
| April 11, 2024 | 2.353B |
| April 10, 2024 | 2.375B |
| April 09, 2024 | 2.431B |
| April 08, 2024 | 2.426B |
| April 05, 2024 | 2.466B |
| April 04, 2024 | 2.435B |
| April 03, 2024 | 2.479B |
| April 02, 2024 | 2.475B |
| April 01, 2024 | 2.555B |
| Date | Value |
|---|---|
| March 28, 2024 | 2.512B |
| March 27, 2024 | 2.527B |
| March 26, 2024 | 2.393B |
| March 25, 2024 | 2.315B |
| March 22, 2024 | 2.265B |
| March 21, 2024 | 2.255B |
| March 20, 2024 | 2.209B |
| March 19, 2024 | 2.203B |
| March 18, 2024 | 2.134B |
| March 15, 2024 | 2.137B |
| March 14, 2024 | 2.135B |
| March 13, 2024 | 2.149B |
| March 12, 2024 | 2.144B |
| March 11, 2024 | 2.153B |
| March 08, 2024 | 2.183B |
| March 07, 2024 | 2.164B |
| March 06, 2024 | 2.182B |
| March 05, 2024 | 2.147B |
| March 04, 2024 | 2.162B |
| March 01, 2024 | 2.159B |
| February 29, 2024 | 2.206B |
| February 28, 2024 | 2.308B |
| February 27, 2024 | 2.318B |
| February 26, 2024 | 2.322B |
| February 23, 2024 | 2.285B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
325.86M
Minimum
Mar 18 2020
3.143B
Maximum
Jun 28 2021
1.449B
Average
1.431B
Median
Dec 30 2020
Market Cap Benchmarks
| ANI Pharmaceuticals Inc | 1.417B |
| Arbutus Biopharma Corp | 488.27M |
| Chimerix Inc | 85.01M |
| Karyopharm Therapeutics Inc | 130.03M |
| Y-mAbs Therapeutics Inc | 752.42M |
Market Cap Related Metrics
| PS Ratio | 11.52 |
| Price to Book Value | 10.22 |
| Price to Free Cash Flow | 291.89 |
| Price | 47.83 |
| Earnings Yield | -0.17% |